ClinicalTrials.gov
ClinicalTrials.gov Menu

Acceptability of Depo-subQ Provera 104 in Uniject vs. Intramuscular Depo-Provera Among HIV+ Women & Providers, Uganda

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01578447
Recruitment Status : Completed
First Posted : April 17, 2012
Last Update Posted : September 18, 2014
Sponsor:
Collaborators:
Society of Family Planning
Bill and Melinda Gates Foundation
Rakai Health Sciences Program
Information provided by (Responsible Party):
Ronald Gray, Johns Hopkins Bloomberg School of Public Health